AbbVie to buy Gilgamesh Pharma Bretisilocin for Major Depressive Disorder Ruchika Sharma29 Aug 2025 12:30 PM ISTNorth Chicago: AbbVie and Gilgamesh Pharmaceuticals Inc. have announced a definitive agreement under which AbbVie will acquire Gilgamesh's lead...
AbbVie completes acquisition of Capstan Therapeutics Ruchika Sharma24 Aug 2025 10:30 AM ISTNorth Chicago, Ill.: AbbVie has announced that it has completed its acquisition of Capstan Therapeutics. With the completion of the acquisition,...
AbbVie announces USD 195 million investment to expand API manufacturing in US Ruchika Sharma17 Aug 2025 1:00 PM ISTNorth Chicago, Ill.: AbbVie has announced a USD 195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic...
AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib for previously untreated patients with Chronic Lymphocytic Leukemia Ruchika Sharma30 July 2025 11:29 AM ISTVENCLEXTA is being developed by AbbVie and Roche.
Ichnos Glenmark Innovation, AbbVie ink pact for investigational cancer drug Ruchika Sharma11 July 2025 2:54 PM ISTNew York: AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), have announced an...
Premarket approval application for Skinvive by Juvederm for neck lines reduction under USFDA review: Abbvie Allergan Aesthetics Ruchika Sharma2 July 2025 3:03 PM ISTIrvine: AbbVie's Allergan Aesthetics has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the...
USFDA approves expanded indication for AbbVie Mavyret for Acute Hepatitis C Virus Ruchika Sharma15 Jun 2025 12:00 PM ISTNorth Chicago: AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for a label expansion for MAVYRET...
AbbVie Emrelis gets USFDA accelerated approval for a type of lung cancer Ruchika Sharma15 May 2025 11:10 AM ISTNorth Chicago: AbbVie has received accelerated approval from the U.S. Food and Drug Administration (FDA) for EMRELIS (telisotuzumab...
USFDA approves AbbVie giant cell arteritis drug Rinvoq in adults Ruchika Sharma30 April 2025 4:30 PM ISTNorth Chicago, Ill.: AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for RINVOQ (upadacitinib), 15 mg, once daily,...
Abbvie seeks USFDA nod for trenibotulinumtoxinE for glabellar lines treatment Ruchika Sharma25 April 2025 11:46 AM ISTNorth Chicago, Ill.: AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for...
Abbvie CEO Robert A Michael to assume additional role of Board Chairman Ruchika Sharma18 Feb 2025 4:30 PM ISTNorth Chicago: AbbVie has announced that its board of directors has unanimously elected chief executive officer (CEO) Robert A. Michael to assume...
AbbVie gets USFDA nod for Emblaveo for treatment of adults with complicated intra abdominal infections with limited or no treatment option Ruchika Sharma8 Feb 2025 11:30 AM ISTNorth Chicago: AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a...
